BetterLife Pharma Inc. (BETR.CN)
CAD 0.11
(0.0%)
CAD 0.11
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 18.43 Thousand | 18.43 Thousand | 22.81 | 85.90 | 1.13 Million |
| Gross Profit | - | -18.43 Thousand | -18.43 Thousand | -22.81 | -85.90 | -1.13 Million |
| Operating Expenses | 3.24 Million | 9.25 Million | 9.96 Million | 7.95 Million | 9.19 Million | 5.59 Million |
| Selling, General and Administrative Expenses | 2.63 Million | 6.56 Million | 4.53 Million | 7.55 Million | 7.74 Million | 5.21 Million |
| Research and Development Expenses | 570.94 Thousand | 2.67 Million | 5.42 Million | 284.7 Thousand | 63.76 Thousand | 364.78 Thousand |
| Other Expenses | 30.35 Thousand | 18.13 Thousand | 26.93 Thousand | -40.35 Thousand | 48.38 Thousand | -8860.00 |
| Cost and Expenses | 3.24 Million | 9.25 Million | 9.96 Million | 7.95 Million | 9.19 Million | 6.72 Million |
| Operating Income | -3.24 Million | -9.46 Million | -10.2 Million | -7.91 Million | -18.73 Million | -6.72 Million |
| Interest Expense | 50.89 Thousand | 67.17 Thousand | 58.34 Thousand | 40.1 Thousand | 428.77 Thousand | 1078.81 |
| Income Tax Expense | - | -271.25 Thousand | 166.66 Thousand | -258.00 | 477.16 Thousand | -160.24 Thousand |
| Earnings before Tax | -2.89 Million | -9.37 Million | -11.99 Million | -36.35 Million | -19.58 Million | -9.25 Million |
| Net Income | -2.88 Million | -9.01 Million | -12.15 Million | -36.35 Million | -19.58 Million | -9.25 Million |
| Earnings Per Share Basic | -0.03 | -0.10 | -0.16 | -1.34 | -1.30 | -1.03 |
| Earnings Per Share Diluted | -0.03 | -0.10 | -0.16 | -1.34 | -1.30 | -1.03 |
| Weighted Average Shares Outstanding | 109.28 Million | 86.56 Million | 75.46 Million | 27.02 Million | 15.03 Million | 9.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 109.28 Million | 86.56 Million | 75.46 Million | 27.02 Million | 15.03 Million | 9.02 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -3.19 Million | -9.24 Million | -9.95 Million | -7.83 Million | -17.4 Million | -6.88 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 1.11 Million | 2.26 Million | 3.2 Million | 730.24 Thousand | 698.62 Thousand | 1.01 Million |
| Selling, General and Administrative Expenses | 840.74 Thousand | 2.15 Million | - | 544.24 Thousand | 565.11 Thousand | 829.77 Thousand |
| Research and Development Expenses | 270.28 Thousand | 114.83 Thousand | - | 185.99 Thousand | 133.5 Thousand | 184.79 Thousand |
| Other Expenses | 57.72 Thousand | 305.43 Thousand | - | -590.55 Thousand | 542.03 Thousand | -78.76 Thousand |
| Cost and Expenses | 1.11 Million | 2.26 Million | 3.2 Million | 730.24 Thousand | 698.62 Thousand | 1.01 Million |
| Operating Income | -1.16 Million | -2.26 Million | -3.2 Million | -730.25 Thousand | -856.47 Thousand | -926.97 Thousand |
| Interest Expense | 210.78 Thousand | 63.1 Thousand | 50.89 Thousand | 36.35 Thousand | 7016.00 | 5872.00 |
| Income Tax Expense | 144.23 Thousand | -102.5 Thousand | -9478.00 | 609.04 Thousand | -169.11 Thousand | -81.2 Thousand |
| Earnings before Tax | -1.44 Million | -2.04 Million | -2.89 Million | -693.48 Thousand | -213.73 Thousand | -1.02 Million |
| Net Income | -1.43 Million | -1.94 Million | -2.88 Million | -1.3 Million | -195.45 Thousand | -1.01 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | - | -0.01 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.02 | - | -0.01 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 120.45 Million | 115.89 Million | 109.28 Million | 115.82 Million | 112.84 Million | 109.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.45 Million | 115.89 Million | 109.28 Million | 115.82 Million | 112.84 Million | 109.19 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.11 Million | -2.26 Million | - | -730.25 Thousand | -156.58 Thousand | -1.09 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
9594
WAY
ASTEC
SURAJEST
PLASTIBLEN
FIPP